There are a wide range of study methods (e.g., positivity thresholds), cancer subtypes, and MUC5AC glycoforms analyzed; however, it is unclear whether these differences could explain any of the variation in reported prognostic relevance. This evidence concerns the gene MUC5AC and cancer.